1. Home
  2. WRBY vs SUPN Comparison

WRBY vs SUPN Comparison

Compare WRBY & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Warby Parker Inc.

WRBY

Warby Parker Inc.

HOLD

Current Price

$20.28

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$50.48

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WRBY
SUPN
Founded
2010
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
WRBY
SUPN
Price
$20.28
$50.48
Analyst Decision
Buy
Strong Buy
Analyst Count
13
5
Target Price
$26.67
$61.60
AVG Volume (30 Days)
2.4M
503.8K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
105.88
N/A
EPS
0.01
N/A
Revenue
$871,905,000.00
$392,755,000.00
Revenue This Year
$14.63
$22.72
Revenue Next Year
$16.46
$18.10
P/E Ratio
$2,033.50
N/A
Revenue Growth
13.04
N/A
52 Week Low
$13.63
$29.16
52 Week High
$31.00
$59.68

Technical Indicators

Market Signals
Indicator
WRBY
SUPN
Relative Strength Index (RSI) 38.10 48.37
Support Level $15.61 $47.43
Resistance Level $20.37 $52.14
Average True Range (ATR) 1.45 1.76
MACD -0.32 0.10
Stochastic Oscillator 6.67 62.29

Price Performance

Historical Comparison
WRBY
SUPN

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: